Dalla Chiesa, M. et al. 2007. Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon a–2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial. Acta Biomedica Atenei Parmensis. 78, 3 (Dec. 2007), 204–209.